Electrochemical miRNA-34a-based biosensor for the diagnosis of Alzheimer’s disease

Abstract

Alzheimer's disease (AD) is the most common dementia type and a leading cause of death and disability in the elderly. Diagnosis is expensive and invasive, urging the development of new, affordable, and less invasive diagnostic tools. The identification of changes in the expression of non-coding RNAs prompts the development of diagnostic tools to detect disease-specific blood biomarkers. Building on this idea, this work reports a novel electrochemical microRNA (miRNA) biosensor for the diagnosis of AD, based on carbon screen-printed electrodes (C-SPEs) modified with two gold nanostructures and a complementary anti-miR-34a oligonucleotide probe. This biosensor showed good target affinity, reflected on a 100 pM to 1 M linearity range and a limit of detection (LOD) of 39 pM in buffer and 94 aM in serum. Moreover, the biosensors response was not affected by serum compounds, indicating selectivity for miR-34a. The biosensor also detected miR-34a in the cell culture medium of a common AD model, stimulated with a neurotoxin to increase miR-34a secretion. Overall, the proposed biosensor makes a solid case for the introduction of a novel, inexpensive, and minimally invasive tool for the early diagnosis of AD, based on the detection of a circulating miRNA overexpressed in this pathology.This work was supported by 0624_2IQBIONEURO_6_E, 2IQBioneuro, Promotion of an R&I network in biological chemistry for the diagnosis and treatment of neurological diseases EP-INTERREG V Spain Portugal (POCTEP), and by Portuguese funds through FCT in the framework of the project PTDC/BTM-MAT/4156/2021. S.D.S acknowledges FCT (Fundação para a Ciência e a Tecnologia, I.P.) for her contract under the Norma Transitória – DL57/2016/CP/CP1360/CT0013.info:eu-repo/semantics/publishedVersio

    Similar works